References
Griffen, E. J., Dossetter, A. G., Leach, A. G. & Montague, S. Drug Discov. Today 18, 725–731 (2018).
Vamathevan, J. et al. Nat. Rev. Drug Discov. 18, 463–477 (2019).
Putin, E. et al. Mol. Pharm. 15, 4386–4397 (2018).
Segler, M. H. S., Kogej, T., Tyrchan, C. & Waller, M. P. ACS Cent. Sci. 4, 120–131 (2018).
Jørgensen, P. B., Schmidt, M. N. & Winther, O. Mol. Inform. 37, 1700133 (2018).
Schneider, G. Mol. Inform. 37, 1880131 (2018).
Kadurin, A., Nikolenko, S., Khrabrov, K., Aliper, A. & Zhavoronkov, A. Mol. Pharm. 14, 3098–3104 (2017).
Dimitrov, T., Kreisbeck, C., Becker, J. S., Aspuru-Guzik, A. & Saikin, S. K. ACS Appl. Mater. Interfaces 11, 24825–24836 (2019).
Gómez-Bombarelli, R. et al. ACS Cent. Sci. 4, 268–276 (2018).
Weininger, D. J. Chem. Inf. Comput. Sci. 28, 31–36 (1988).
Schneider, G. & Fechner, U. Nat. Rev. Drug Discov. 4, 649–663 (2005).
Brown, N., Fiscato, M., Segler, M. H. S. & Vaucher, A. C. J. Chem. Inf. Model. 59, 1096–1108 (2019).
Polykovskiy, D. et al. Preprint at https://arxiv.org/abs/1811.12823v3 (2018).
Merk, D., Friedrich, L., Grisoni, F. & Schneider, G. Mol. Inform. 37, 1700153 (2018).
Zhavoronkov, A. et al. Nat. Biotechnol. 37, 1038–1040 (2019).
Colangelo, M. LinkedIn https://www.linkedin.com/pulse/pharmas-alphago-moment-first-time-ai-has-designed-new-colangelo/ (3 September 2019).
Silver, D. et al. Nature 529, 484–489 (2016).
Gao, M. et al. J. Med. Chem. 56, 3281–3295 (2013).
Tan, F. H., Putoczki, T. L., Stylli, S. S. & Luwor, R. B. Oncotargets Ther. 12, 635–645 (2019).
Canning, P. et al. J. Mol. Biol. 426, 2457–2470 (2014).
Stewart, K. D., Shiroda, M. & James, C. A. Bioorg. Med. Chem. 14, 7011–7022 (2006).
Hessler, G. & Baringhaus, K. Drug Discov. Today Technol. 7, e263–e269 (2010).
Leach, A. R. & Lewis, R. A. J. Comput. Chem. 15, 233–240 (1994).
Stahl, M. & Bajorath, J. J. Med. Chem. 54, 1–2 (2011).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
W.P.W. is employed by, and M.M. is a member of the Board of Diretors of, Relay Therapeutics.
Rights and permissions
About this article
Cite this article
Walters, W.P., Murcko, M. Assessing the impact of generative AI on medicinal chemistry. Nat Biotechnol 38, 143–145 (2020). https://doi.org/10.1038/s41587-020-0418-2
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41587-020-0418-2
- Springer Nature America, Inc.
This article is cited by
-
MolScore: a scoring, evaluation and benchmarking framework for generative models in de novo drug design
Journal of Cheminformatics (2024)
-
Generative AI for designing and validating easily synthesizable and structurally novel antibiotics
Nature Machine Intelligence (2024)
-
Analyzing behavioral intentions toward Generative Artificial Intelligence: the case of ChatGPT
Universal Access in the Information Society (2024)
-
AI is a viable alternative to high throughput screening: a 318-target study
Scientific Reports (2024)
-
AI-driven molecular generation of not-patented pharmaceutical compounds using world open patent data
Journal of Cheminformatics (2023)